work with

Sanofi-Genzyme BioVentures

The Sanofi-Genzyme BioVentures Fund allows us to build longstanding relationships with today’s innovators that could lead to future product opportunities.
— Bernard Davitian
Vice President and Managing Director, Sanofi-Genzyme BioVentures

Sanofi-Genzyme BioVentures invests in early-stage innovative life science companies of strategic interest.
About Sanofi-Genzyme BioVentures

Sanofi-Genzyme BioVentures (SGBV) is different from traditional venture capital firms: we only invest in early-stage life science companies developing innovative products that may become future Sanofi products. We also back our financial support with world class technical and strategic guidance through access to the Sanofi and Genzyme teams.

SGBV is the corporate venture capital arm of Sanofi. Previously known as Genzyme Ventures, SGBV has a recently expanded mandate to invest across the more expansive businesses of Sanofi.

The SGBV team is based in Cambridge, Mass., and invests all over the world.

Learn more on the Sanofi-Genzyme Bioventures website.

Partnering with Sanofi Genzyme

Collaboration drives our external partnerships, where we seek complementary strengths that can help us bring groundbreaking new products to market.

Learn more about partnering

Last Updated: 5/13/2015
Contact Us
Sanofi-Genzyme BioVentures

500 Kendall Street
Cambridge, MA 02142

Independent Research
Sanofi Genzyme's Support

Find out about Sanofi Genzyme's investigator-sponsored studies program that supports outside researchers whose work is relevant to ours.